This article from 2005 explains how the Food and Drug Administration (FDA) announced its intention to include information on potential psychiatric side effects on the labels of a class of drugs that encompasses Concerta and Ritalin, both commonly prescribed treatments for attention deficit hyperactivity disorder (ADHD). Additionally, the FDA planned to probe other ADHD medications to determine if they present similar issues. This is the exact drug I, Bob Schwartz, was prescribed so many years ago. It had devastating effects.
Read the full article below: